Oscar Health, Inc. (OSCR)
NYSE NYSE Primary 
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Lags Revenue Estimates
Oscar Health, Inc. (OSCR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.66 per share a year ago.
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $16.28, indicating a -0.12% shift from the previous trading day.
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $15.65, marking a -1.57% move from the previous day.
Oscar Health: Trump Uncertainty Creates Buying Opportunity
Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 years. Despite not being profitable yet, Oscar Health is projected to achieve GAAP profitability in FY24, with EPS expected to grow to $0.51 by FY25. The key risk is the repeal of ACA by the Trump administration, which would significantly impact the affordability of health insurance premiums for individual buyers.
Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $14.17, representing a -0.07% change from its previous close.
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.44, indicating a -1.03% shift from the previous trading day.
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Note
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.58, representing a -1.59% change from its previous close.
Oscar Health, Inc. (OSCR) Ascends While Market Falls: Some Facts to Note
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.50, representing a +0.9% change from its previous close.
Oscar Health CEO on fixing health insurance industry: I would eliminate employer-sponsored insurance
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss the state of the health insurance industry in the wake of the killing of UnitedHealthcare CEO Brian Thompson, public anger over insurance claim denials, what can be done to fix the health care system, and more.
US healthcare industry 'is now broken,' Oscar Health CEO
After UnitedHealthcare (UNH) CEO Brian Thompson was fatally shot in New York City last week, various health insurance providers have removed executives' biography pages from the corporate websites. NYPD investigators have found this shooting to be "a pre-meditated, pre-planned, targeted attack" as the manhunt for the assailant continues.
Future of health care lies in individual insurance market, says Oscar Health CEO Mark Bertolini
Mark Bertolini, Oscar Health CEO, joins 'Squawk Box' to discuss what the new administration means for the health care sector, ways to roll back parts of Obamacare, and much more.
Oscar Health (OSCR) Upgraded to Buy: What Does It Mean for the Stock?
Oscar Health (OSCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
